Tags: Drug.

Tabalumab (LY 2127399) is an anti-B-cell activating factor (BAFF) human monoclonal antibody designed for the treatment of autoimmune diseases and B cell malignancies.Tabalumab was developed by Eli Lilly and Company.A phase III clinical trial for rheumatoid arthritis was halted in Feb 2013.

ATC prefix
none
CAS number
1143503-67-6

Loading...

This page contains content from the copyrighted Wikipedia article "Tabalumab"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.